The maternal determinant VegT is required for both endoderm and mesoderm formation by the Xenopus embryo. An important downstream mediator of VegT action is Xsox17, which has been proposed to be induced in cell-autonomous, then signal-dependent phases. We show that Xsox17 is a direct VegT target, but that direct induction of Xsox17 by VegT is rapidly inhibited. This inhibition is relieved by TGF-␤ signalling, to which the future endoderm cell is sensitised by VegT, resulting in the observed dependence on cell contact for maintained Xsox17 expression. We propose that this change in regulation is a consequence of a VegT-induced repressor, inhibiting direct induction of early endoderm markers by VegT, and contributing to the formation of the boundary of the endodermal domain.
Introduction
The endodermal tissues of the Xenopus embryo are derived from the yolky cells of the blastula vegetal hemisphere, which also induce the overlying equatorial annulus of cells to form the mesoderm. Specification of the endoderm is mediated by the activity of the T-box transcription factor VegT, whose maternal transcripts are localised to the vegetal hemisphere of the egg (Horb and Thomsen, 1997; Lustig et al., 1996; Stennard et al., 1996; Zhang and King, 1996) . These early authors showed that VegT is capable of inducing mesodermal gene expression in animal cap cells, and it soon emerged that it could also induce endoderm (Horb and Thomsen, 1997; Clements et al., 1999; Chang and Hemmati-Brivanlou, 2000; Xanthos et al., 2001) . Depletion of maternal VegT mRNA results in loss both of endodermal markers in the early embryo and of the vegetal mesoderm-inducing signal, indicating that VegT is essential for endoderm, as well as mesoderm formation in the Xenopus embryo (Zhang et al., 1998; Xanthos et al., 2001) .
It has been shown that VegT is the source of a complex TGF␤ signal, which includes Xnrs 1, 2, 4, 5, and 6, and Derrière (Clements et al., 1999; Kofron et al., 1999; Rex et al., 2002; Sun et al., 1999; Takahashi et al., 2000) . This signal is essential both for the induction of the mesodermal annulus (Hemmati-Brivanlou and Melton, 1992; Piccolo et al., 1999) and for maintenance of early endodermal gene expression (Zhang et al., 1998; Clements et al., 1999; Yasuo and Lemaire, 1999; Chang and Hemmati-Brivanlou, 2000; Engleka et al., 2001; Xanthos et al., 2001) . Of the TGF␤family signals present in the vegetal pole, it has been argued, from kinetic arguments, that some appear to be direct targets of VegT, and constitute a "primary" signal (Xnrs 4, 5, and 6 and Derrière) (Clements et al., 1999; Sun et al., 1999; Rex et al., 2002) , which is capable of inducing further TGF␤ expression. It is not yet clear how each individual component of this signal, which may include heterodimers between different TGF␤ family members, contributes to the activity of VegT with respect to mesoderm induction and endoderm maintenance, and it is possible that there is a high degree of functional redundancy. Other direct or indirect downstream targets of VegT include transcription factors of the Mix/Bix/Mixer family, GATAs 4, 5, and 6, and Xsox17␣ and ␤, all of which have been implicated in endoderm development (Hudson, 1997; Tada et al., 1998; Casey et al., 1999; Clements et al., 1999; Weber et al., 2000; Xanthos et al., 2001) .
We have previously demonstrated that the zygotic HMGdomain transcription factors Xsox17␣ and ␤ play an essential role in the formation of endoderm in the Xenopus embryo (Clements et al., 2000; Hudson et al., 1997) . Xsox17 transcripts are localised to cells fated to become endodermal derivatives, ectopic expression of Xsox17 in animal caps induces the expression of endodermal markers, and a dominant interfering construct inhibits expression of endogenous endodermal genes. In addition to inducing the formation of endoderm, Engleka et al. (2001) have proposed that Xsox17 also functions to suppress the activation of mesodermal genes in the endodermal domain, although this could be caused by distant effects, through shifting the fate of mesoderm cells into endoderm. Such effects on cell fate have in fact been recorded (Clements and Woodland, 2000) . Hence, Xsox17 is an important mediator of the endoderminducing activity of VegT.
Previously we showed that the induction of Xsox17 by VegT occurs in two phases; the initial induction occurs cell-autonomously, but cell contact is required for expression to be maintained (Clements et al., 1999) . This twophased model was independently proposed by Yasuo and Lemaire (1999) . Cycloheximide experiments on whole embryos showed that Xsox17 is a direct target of a maternal component, suspected to be VegT (Engleka et al., 2001; Yasuo and Lemaire, 1999) . We are now able to demonstrate that Xsox17 is, at least transiently, a direct target of VegT. Xenopus has a statistical fate map, with some cell scattering through late blastula and gastrula stages, so if this simple direct induction by a localised mRNA was maintained, ectopic endoderm would develop from the dispersed cells. However, this direct induction appears to be rapidly inhibited, and continued expression of Xsox17 requires a VegTderived TGF␤ signal, and hence cell contact. Added to this is a synergism between VegT and TGF␤ signalling by which VegT increases the sensitivity of cells to TGF-␤ signalling. Together, these processes are proposed to contribute to the delineation of coherent endodermal and mesodermal domains within the embryo and to counteract effects of the scattering of cells which occurs in Xenopus gastrulation.
Materials and methods

Biological methods
Embryos were cultured and dissected by standard methods (Wilson et al., 1986) . All RNA injections were of 10 nl bilaterally at the two-cell stage, unless stated otherwise. For animal cap explants, injection was into the animal pole; for vegetal explants, injection was into the vegetal pole. Injections were performed in 6% Ficoll in 0.1ϫ Barths' saline, and embryos were cultured at 13, 18, or 23°C. For dissection, embryos were transferred to 1ϫ Barths' saline at stage 8.5, and dissected fragments were cultured in 0.5ϫ Barths' medium supplemented with 1 mM CaCl 2 and 10 units/ml gentamycin.
For experiments involving disaggregation of animal cap explants, the explants were dissociated in calcium-and magnesium-free Barths' medium, and cultured at 21°C with frequent agitation. The portion of the outer layer of cells which did not disaggregate efficiently was discarded.
Cycloheximide and dexamethasone treatment
Explants or whole embryos were incubated in 10 g/ml cycloheximide for 30 min prior to induction with dexamethasone. Dexamethasone was dissolved in ethanol and was added to a final concentration of 2 M; the cycloheximide was maintained throughout the incubation. Ethanol alone was added to control samples.
RNA extraction, cDNA synthesis, and RT-PCR
Total RNA was prepared from embryos and explants as described previously (Hudson et al., 1997; Richardson et al., 1995) . Quantitative RT-PCR analysis of mRNAs was based on the method of Rupp and Weintraub, (1991) , as detailed in Hudson et al. (1997) . Visualisation and quantitation were performed by using a Molecular Dynamics phosphorimager with ImageQuant software.
PCR primers and conditions are as described previously (Clements et al., 1999; Hudson et al., 1997) . These methods and primers can be accessed at http://www.bio.warwick. ac.uk/woodland/Hrw1b.htm.
Transcriptions for injection
All constructs are as described previously (Clements et al., 1999) , except VegTGR. VegTGR was generated by PCR amplification of the human glucocorticoid receptor ligand binding domain (Tada et al., 1997) , which was then cloned downstream of, and in-frame with, the VegT coding region in pSPJC2L. Transcripts were generated by XhoI digestion and SP6 transcription using the Ambion mMessage mMachine SP6 Transcription Kit.
All transcriptions were carried out by using mMessage mMachine (Ambion). ␤-Galactosidase transcripts were generated by XhoI digestion of SP6nuc-Beta-gal (Smith and Harland, 1991) , followed by SP6 transcription. pSPVegT was linearised with XhoI and transcribed with SP6. Other expression clones were processed according to the authors' instructions.
In situ hybridisation
Albino embryos were injected in a single A-tier blastomere at the 16-or 32-cell stage with 100 pg VegT and 100 pg ␤-galactosidase mRNAs. Embryos were treated with 10 g/ml cycloheximide as described in the text. The embryos were cultured to the stages indicated, then fixed for 30 min in MEMFA (0.1 M Mops, pH 7.4, 2 mM EGTA, 1 mM MgSO 4 , 3.7% formaldehyde). ␤-Galactosidase expression was detected by incubation in ␤-gal buffer (0.1 M NaPi, pH 7.2, 2 mM MgCl 2 , 0.02% NP-40, 0.01% Na deoxycholate, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mM EGTA) with 0.4 mg/ml X-gal at 37°C for 1 h. The embryos were then refixed in MEMFA at 4°C overnight, and in situ hybridisation was carried out essentially as described by Harland (1991) .
For Xsox17␤, antisense riboprobes for in situ hybridisation were generated by EcoRI digestion of pBS-Xsox17␤ (Hudson et al., 1997) , followed by in vitro transcription using T7 RNA polymerase, and DIG RNA labelling mix (Boehringer).
Results
Xsox17 is a direct target of VegT
Previously, we showed that the initial induction of Xsox17␣ and ␤ by VegT occurs in disaggregated cells, indicating a cell-autonomous mechanism. One cannot, however, infer that there is direct induction of Xsox17 by VegT, since several successive intracellular gene inductions could be involved. Subsequently, cell contact is required for the induction of Xsox17 to be maintained, and additionally, we demonstrated a requirement at some level for a TGF-␤ signal in induction of both endodermal and mesodermal marker by VegT. We formulated a model based on these data in which the endodermal field was initially determined cell-autonomously by maternal VegT-expressing cells, but where this field was rapidly refined by VegT-derived TGF␤ signalling. Although this is consistent with observations that Xsox17␣ expression initiates in embryos at MBT in the absence of protein synthesis (Yasuo and Lemaire, 1999; Engleka et al., 2001; ) , other authors (Kofron et al., 1997) have proposed a model in which VegT induces a TGF-␤ signal, and this signal subsequently induces Xsox17. This latter model may be an oversimplification, since it is inconsistent with our observation that Xsox17 expression is induced, albeit transiently, by VegT in the absence of cell contact.
Xsox17 is actually first expressed at low levels throughout the embryo before MBT, but then rapidly accumulates in the future endoderm after MBT. This perhaps suggests, but does not prove, that Xsox17 is a direct target of the maternal endoderm induction pathway. In order to determine whether Xsox17 is indeed a direct target of VegT, we constructed a dexamethasone-inducible VegT by fusing the ORF of VegT to that encoding the glucocorticoid receptor ligand-binding domain (VegTGR). This enabled us to test the induction of Xsox17 by VegT in the absence of protein synthesis. Animal caps were taken from embryos injected with 100 pg of VegTGR mRNA at the two-cell stage and were preincubated for 30 min with the protein synthesis inhibitor cycloheximide before addition of dexamethasone at stage 9. Caps were harvested at stage 10.5 and assayed for induction of endodermal and mesodermal markers by RT-PCR ( Fig. 1 ). In the absence of dexamethasone, levels of these markers were indistinguishable from control levels in caps from uninjected embryos. In the presence of dexamethasone, a range of endodermal and mesodermal markers was induced, indicating that the VegTGR fusion protein shows similar activity to the wild type protein. Certain markers are sometimes weakly induced by cycloheximide; these include Xnr1 and Xnr4 (see also Fig. 2 ) and on occasion Xsox17␣ (not shown). This can occur even when the VegTGR construct is absent ( Fig. 1 ). Induction of markers by cycloheximide has previously been reported in the Xenopus embryo (e.g., Tadano et al., 1993) . Animal cap cells contain low levels of VegT, which may be responsible for this effect if it is repressed by an inhibitor sensitive to cycloheximide, as the model we propose later predicts.
In the presence of dexamethasone and cycloheximide, expression of the mesodermal markers Xbra and Eomes was Fig. 1 . Induction of endoderm and mesoderm markers by VegTGR. Embryos were injected bilaterally at the two-cell stage with 100 pg of VegTGR mRNA, and animal cap explants from these and control embryos were taken at stage 9. These were treated as indicated with dexamethasone (DEX) alone, cycloheximide (CHX) alone, or DEX and CHX (where the CHX treatment preceded the addition of DEX by 30 minutes). Animal cap explants were harvested at stage 10.5 and analysed by RT-PCR. The induction of the endodermal markers Xsox17␣ and ␤ is resistant to cycloheximide treatment, indicating that it occurs in the absence of protein synthesis. The induction of both Xbra and Eomes is, however, sensitive to inhibition as expected if they are induced through VegT-dependent signals. The cDNA linearity was performed with cDNA from the whole embryo samples, representing 0.25, 0.5, and 1.0 times the input in the other lanes. reduced to control levels, showing that they are not direct targets of VegT. This observation confirms the efficacy of the cycloheximide treatment, which was also evident from the phenotype of treated whole embryos, in which cell division and subsequently gastrulation was blocked. The conditions used were identical to those of Tada et al. (1997) for study of an inducible XbraGR, and inhibit protein synthesis by Ͼ90% (also, Cascio and Gurdon, 1987; Sokol, 1994) . The induction of Xsox17␤ was unaffected by the presence of cycloheximide, as was the induction of Xnr4, Mix.1, Mixer, and Derrière (Figs. 1 and 2). These data therefore confirm our previous conclusion that Xsox17 is a cell-autonomous target of VegT, but more importantly show that it is a direct target. (Xsox17␣ behaves in the same way as Xsox17␤; data not shown.)
According to our previous data (Clements et al., 1999) , we would have anticipated that cycloheximide would have significantly inhibited the induction of Xsox17 and Mix.1 at stage 10.5, since using a dominant negative receptor showed that the expression of these markers is heavily dependent on TGF␤ signalling by this stage. However, this is not the case. This apparent inconsistency is resolved below.
Our previous data indicated that Xsox17 and other endodermal markers are targets of both VegT and a VegTderived TGF␤-signal. We examined the effect of cell disaggregation on the level of induction of these markers in order to determine the relative importance of cell autonomous and non-cell-autonomous modes of induction. Animal caps were disaggregated before cycloheximide and dexamethasone treatment and the levels of expression of the markers Xsox17, Mix.1, Xnr4, and Derrière compared with the levels in intact caps. We also induced VegTGR at stage 9 and at stage 10.5, to determine whether there was any change in the competence of the animal cap to respond to VegT over this period (Fig. 2) . It was found that, for animal caps treated for 2 h with dexamethasone at stage 9 or 10, the level of induction of most markers was similar in intact and dissociated samples, again implying an insignificant role for signalling over the induction period and indicating the way that the cap cells respond to VegT did not change during this period.
A consistent observation from these experiments was that the induction of Xnr4, Xsox17, and Mix.1 by VegTGR was increased by the presence of cycloheximide, to the extent that, at stage 10, Mix.1 was only induced in the presence of cycloheximide. These markers were not upregulated by cycloheximide alone, and induction of Derrière was not affected in the same manner. We considered two possible interpretations of this result: (1) that there may be an endogenous, VegT-independent, inhibitor present in animal caps which accumulates during blastula and gastrula stages, and which functions to limit VegT activity, or (2) that VegT may be the source of an inhibitor of its own activity. Cycloheximide treatment would prevent synthesis of this inhibitor and de-repress transcription of VegT targets. The former model is inconsistent with our observation that Xsox17 expression can still be induced by VegTGR at the gastrula stage in disaggregated cells (Fig. 2) .
There are other compelling reasons to propose an inhibitor. As shown previously (Clements et al., 1999; Yasuo and Lemaire, 1999) , maintenance of endogenous Xsox17 expression in vegetal poles at stage 9 requires cell contact, and Markers identified as being direct targets of VegT were induced in disaggregated cells treated with DEX for 2 h at stage 9 (harvested at stage 10) and stage 10 (harvested at stage 11). Otherwise, details are as in Fig. 1 , except that the linearity test extends to 2.0 times the normal cDNA input. By stage 10/11, it is clear that the presence of cycloheximide has a positive effect on the induction of Xsox17␤ and Mix.1 by VegT.
this is also seen here in animal caps ectopically expressing VegT. This is despite the continued presence of VegT mRNA and VegT protein in the vegetal pole , as well as in animal cap cells in our injection experiments. Other VegT targets, including Derrière, Xnr4, and Activin, do not show this effect, but continue to be expressed in disaggregated cells (Clements et al., 1999) .
To explain this switch to signal dependence, we propose that the direct induction of Xsox17 by VegT is rapidly blocked by a repressor, which is overridden by the VegTderived TGF␤ signal, resulting in the observed change from cell-autonomous to cell-contact-dependent expression. In this model, cycloheximide will block synthesis of the TGF␤ signal, but also of the repressor, hence direct induction of target genes will be maintained, which is what we see in Fig. 2 .
Since there are currently no candidates for this hypothetical inhibitor, complete confirmation of this model awaits further data, such as the characterisation of the Xsox17 promoter. However, we are able to make testable assumptions based on this model. Previously, we demonstrated nonautonomous induction of both Xbra and Xsox17 by ectopic VegT is gastrula animal caps using in situ hybridisation (Clements et al., 1999) . The clones that developed displayed a pattern of endodermal and mesodermal gene expression exactly analogous to the pattern in the whole embryo, i.e., Xsox17 expression at the centre of the VegTcontaining clone and Xbra in the periphery and beyond it. According to the model above, we should be able to see the switch from cell autonomous to nonautonomous induction of Xsox17 using this method, and we would also predict that this switch would not occur in the presence of cycloheximide, since neither the repressor nor the TGF␤ signal would be synthesised. If Xsox17 was at all stages downstream of TGF-␤ signalling, as has been suggested (Xanthos et al., 2001) , one might expect that Xsox17 expression would be delayed after MBT. Then, when the signal had built up sufficiently to induce endoderm, it would occupy the very centre of the clone from the onset of its expression, slowly expanding as the signal builds up. In contrast in the twophase model, there would at first be a wide expression area, progressively contracting. These alternative possibilities are tested in the next section.
Induction of Xsox17 by VegT assayed by in situ hybridisation
Clones of cells expressing VegT and ␤-galactosidase as a lineage marker were generated by injecting mRNAs into single animal hemisphere blastomeres of albino embryos at the 16-or 32-cell stage. Embryos were fixed at the stages indicated, stained for ␤-galactosidase activity to identify VegT-expressing cells, and then induced Xsox17␤ expression was detected by in situ hybridisation. After the first sample of embryos was harvested at early stage 9, half of the remaining embryos were treated with cycloheximide.
Examination of the caps of treated embryos showed that, whilst it happened very slowly, by the midgastrula stage, the cells had become smaller, i.e., cell division had not been blocked (see Fig. 3 ). This suggests that either that there was enough residual protein synthesis to permit slow cell division in these embryos, or that cells can eventually pass through protein synthesis-dependent checkpoints in longterm cycloheximide culture.
At early stage 9, it can be seen that Xsox17␤ expression coincides on a cell-by-cell basis with VegT/␤-galactosidase, indicating that the induction of this marker is occurring in a cell-autonomous manner (Fig. 3A) . However, in the untreated embryos, by stages 10 and 10.5, Xsox17␤ expression occupies a domain in the centre of the clone of VegTexpressing cells (Fig. 3B and D) . This is consistent with initial nonautonomous induction of this marker, where the inducing signal is sufficient to induce, or to maintain induction of Xsox17␤ expression only in the centre of the clone (previously, we showed that the cells around the periphery of such a clone express the mesodermal marker Xbra; Clements et al., 1999) . In contrast, in the cycloheximide treated embryos, the induced Xsox17␤ remains coincident with the VegT-expressing cells, consistent with continued cell-autonomous induction ( Fig. 3C and E) , as predicted from our inhibitor model. Thus, the clonal data support the two-phase model of Xsox17 induction.
Synergy between VegT and TGF␤ in the induction of mesoderm and endoderm markers
Previously, we quantified the levels of a number of mRNAs, encoding TGF␤ family members, in animal cap explants ectopically expressing VegT. We noted that the levels of these transcripts induced by VegT were substantially lower than the levels of in vitro transcribed mRNA required to be injected into embryos to induce endoderm markers in animal cap explants (Clements et al., 1999) . For example, we showed that the sum of Xnr1, 2, and 4 expression is only 35 fg at stage 9 in a VegT-injected cap, rising to 270 fg in a stage 11 cap. With mRNAs engineered for high level expression, it required 20 pg of Xnr1, and 50 pg of Xnr2 or 4 mRNAs individually to induce Xsox17 expression (data not shown). [While in whole embryos there is higher expression of these molecules, this is because of their high expression in the dorsal mesoderm and endoderm (Spemann and Nieuwkoop Centres); in contrast, Xsox17 is evenly expressed in the vegetal pole and therefore cannot require such high signal levels.]
The lack of concordance between the apparent minimum requirement for injected TGF␤ transcripts with respect to endoderm marker induction, and the amounts of the same transcripts induced by VegT, suggested that there might be a synergising factor in vegetal poles; this might be VegT itself, or a downstream effector of VegT, or indeed a molecule independent of VegT. In order to test this hypothesis, we injected VegT RNA into embryos at the two-cell stage, Fig. 3 . Induction of Xsox17␤, assayed by in situ hybridisation to clones of VegT-expressing cells. Clones of cells ectopically expressing VegT were generated by injecting 100 pg of VegT mRNA and 100 pg of ␤-galactosidase mRNA into single animal hemisphere blastomeres of 16-or 32-cell albino embryos. Embryos were processed at the stages indicated for ␤-galactosidase activity and by in situ hybridisation for Xsox17␤ expression. (A) At stage 9, the in situ signal (purple/brown, cytoplasmic), coincides closely with the VegT-expressing cells (dark blue, nuclear), consistent with cell-autonomous induction of Xsox17␤. At this point, half the embryos were treated with 10 g/ml cycloheximide. When assayed at stages 10 (B) and 10.5 (D), Xsox17␤-expressing cells occupy a central domain, which does not include all of the VegT-expressing cells, and which has a smooth boundary with nonexpressing cells. In contrast, embryos treated with cycloheximide, assayed at the same time points, continue to colocalise VegT and Xsox17␤ (C, stage 10; E, stage 10.5). In (C), the blue ␤-gal staining is light, enabling the Xsox17 in situ signal to be seen more easily. dissecting and disaggregating animal caps at stage 8.5-9 in order to eliminate the effect of VegT-derived TGF␤ signalling. The disaggregated cells were then treated with exogenously added activin protein (human recombinant activin A). This is a widely used mimic of the endogenous VegT signal. The endogenous signal does contain small amounts of activin (Clements et al., 1990) , but is more substantially composed of Xnrs.
Levels of VegT that induce Xsox17 in intact caps fail to generate such an induction in disaggregated cells when assayed at stage 10.5 (Fig. 4, second panel) . The lowest level of activin used in these experiments is also insufficient to induce significant amounts of Xsox17, or even Xbra, in either intact caps or disaggregated cells (Fig. 4, righthand two panels). The intermediate (but not lowest) activin level does induce Xbra in the intact animal caps, perhaps because activin induces secondary expression of TGF␤s, thus raising the overall signal level in the intact caps. These signals would be diluted away from disaggregated cells. However, when disaggregated animal caps expressing VegT are treated with these low levels of activin, the induction of Xsox17 (and Mix.1, Xbra, and Eomes) is restored to the level in intact caps (or even exceeds this level). Thus, VegT and TGF␤ signals synergise in the induction of both mesoderm and endoderm, and the low endogenous levels of TGF␤s are likely to be sufficient to maintain endodermal expression in cells containing VegT, but not induce expression in naïve cells. It will also be noted that there is a sensitisation to induce Xbra. This coinduction of Xbra and Xsox17 has frequently been observed and is hard to interpret. Presumably, it occurs in different cells and may result here from variations in the amount of injected VegT in blastomeres. mRNA diffuses relatively slowly in egg cyto-plasm and may be partitioned by cleavage before it can become evenly distributed.
Discussion
Previously, we showed that the induction of Xsox17 by VegT was a two-step process, comprising an initial cell autonomous induction, followed by maintenance of expression by signalling. Here, we confirm and extend these observations, using an inducible construct to demonstrate that, in the first phase, Xsox17 is a direct target of VegT, and we propose that the switch to signal/contact-dependent expression is mediated by a VegT-induced repressor, whose action can be overridden by low-level activin signalling in cells sensitised by VegT.
We utilised a dexamethasone-inducible VegTGR fusion construct to investigate the induction of Xsox17 by VegT in the absence of protein synthesis. Treatment with dexamethasone results in translocation of the fusion protein into the nucleus and the onset of transcription. Xsox17 transcription was induced by VegTGR in the presence of cycloheximide, which would prevent the synthesis of intermediate gene regulators. This is a model experiment, but the fact that Xsox17 induction occurs immediately on genome activation, in cells containing VegT and in a fashion wholly dependent on VegT (Zhang et al., 1998) , means that Xsox17 must be a natural direct target of VegT in vivo. This is consistent with the observations of Yasuo and Lemaire (1999) and Engleka et al. (2001) , but the prolonged expression of Xsox17 in cycloheximide is superficially inconsistent with our own previous observation that Xsox17 expression rapidly becomes dependent upon signalling. Fig. 4 . Synergism between VegT and activin in the induction of mesoderm and endoderm markers. Animals caps from control embryos or those injected bilaterally at the two-cell stage with 100 pg VegT mRNA were cultured intact or disaggregated in the presence of human recombinant activin A (0.2, 1.0, and 5 ng/ml). The lowest level of activin used was insufficient to induce any of the assayed markers at stage 10.5 in control caps. In intact caps expressing VegT, addition of activin does not significantly increase the level of the markers assayed over the level with VegT alone. Disaggregation of the animal caps results in a dramatic decrease in the levels of these markers. Application of even the lowest amount of activin is, however, sufficient to restore expression to the levels seen in nondisaggregated caps.
In order to reconcile these data, and other observations, we propose the existence of a VegT-derived inhibitor of VegT induction of Xsox17 and Mix.1 (Fig. 5 ). This factor would antagonise the direct effect of VegT on the Xsox17 promoter, but permit stimulation by TGF␤ signals, resulting in the observed dependence on cell contact of Xsox17 expression; thus the induction of Xsox17 by VegT becomes signal-dependent, even though the cells still contain large amount of VegT, which should induce Xsox17 directly. Currently, we do not know the identity of this inhibitor; analysis of the Xsox17␣ promoter is underway and should prove fruitful in this respect.
Since the two phases of Xsox17 activation are shown by vegetal poles (Clements et al., 1999; Yasuo and Lemaire, 1999) , the inhibition of VegT activity must also occur in vegetal poles and be an important endogenous regulatory mechanism, supporting the hypothesis that the hypothetical inhibitor is a downstream target of VegT, the key maternal initiator of endoderm formation. It is also notable that, according to Yasuo and Lemaire (1999) , cycloheximide leads to maintained expression of Xsox17 and Mix.1, but not Mixer, in vegetal poles, indicating that the effects we report in model experiments with VegT also apply to the normal embryo. Our model also explains why, in disaggregated animal caps, Mix.1 is induced only in the presence of cycloheximide-normally by stage 10.5, the induction of Mix.1 by VegT is almost wholly signal dependent, and hence cell-contact-dependent. In the model outlined above, this would be because the direct induction by VegT is efficiently blocked. In the presence of cycloheximide, direct induction by VegT continues in the absence of the repressor, and Mix.1 continues to be expressed, as it does in vegetal poles.
Synergy between VegT and TGF␤ signalling
Endogenous levels of mRNAs encoding TGF␤ signals are substantially lower than amounts of in vitro synthesised RNAs required to induce endoderm in the animal cap assay. It is likely that this is because several inductive pathways synergise in vivo, and so cells are much more sensitive to low levels of signalling.
We have shown that cells expressing VegT respond to lower levels of TGF␤ signalling, by inducing Xsox17 expression, than those that do not express VegT. In these model experiments, animal cap cells expressing ectopic VegT were disaggregated in order to eliminate the effect of TGF␤ signals induced by VegT, and these endogenous signals were replaced with known amounts of activin protein, applied exogenously. One implication of these data is that the vegetal TGF␤ signal should be insufficient to induce endodermal markers in naïve animal caps, and indeed we have been unable to induce Xsox17 expression in animal caps grafted to vegetal explants (not shown). This fits the observation that small animal pole fragments grafted into the extreme vegetal pole formed the intermediate mesoderm tissue muscle, rather than endoderm (Jones and Woodland, 1987) . Moreover, core endodermal gene expression (Mixer, Xsox17␣, Gata5, Xhex, and Cerberus) could not be restored to VegT-depleted caps by grafting onto unmanipulated vegetal poles (Xanthos et al., 2001) . However, Bix4, Milk, and Xlim1 expression was partially recovered. This may be because they are not expressed throughout the future endoderm and are also mesodermal. Thus, they could be regulated in a different way from genes expressed exclusively pan-endodermally.
The issue arises as to the way VegT induces increased responsiveness to activin. Arkadia is one gene product that converts mild activin signals to those capable of inducing endoderm Niederlander et al., 2001) . However, we showed that animal cap levels of Arkadia are not changed by VegT, and Arkadia is thought to be controlled at the level of transcription. An alternative is the Mix/Bix group of genes. Bix genes were isolated as T box targets and are capable of inducing endoderm, including Xsox17 expression (Casey et al., 1999; Tada et al., 1998) . We also show that both Mix.1 and Mixer are direct Xsox17 targets. Mixer has been proposed to maintain Xsox17 expression in vivo, since it induces it in an animal cap and endogenous Xsox17 expression is sensitive to Mixer::EnR, but Mixer transcription starts after that of Xsox17 (Henry and Melton, 1998). Xsox17 does not itself induce Mixer or any other Mix/Bix group gene, so they would have to be provided independently by VegT action. Thus, this group of genes is an excellent candidate for being at least part of a sensitising pathway, but proving this through antisense reagents would be complicated considering the number of genes involved. Our model would fit the hypothesis that only cells both containing VegT and receiving a low TGF-␤ signal become endoderm.
One unexpected result is that there seems to be synergy between VegT and activin in the induction of Xbra as well as Xsox17. In vivo Xbra expression seems to occur primarily in cells initially not containing maternal VegT, although they transcribe it by the onset of gastrulation . A possible explanation may be that the dosage of VegT is important, and the levels of VegT mRNA across an injected animal cap will vary; however, it could be relevant that the zygotic VegT expression in the mesoderm of the gastrula occurs when competence to respond to activin has fallen, and this may normally promote mesodermal gene expression.
How might these observations on the mode of action of VegT relate to patterning in the embryo? They may reflect mechanisms that facilitate the formation of sharp boundaries between germ layers. Maternal VegT transcripts define a vegetal domain competent to become endoderm. If expression of (maternal) VegT was the only factor determining endodermal fate, the cell mixing that normally occurs in Xenopus, yielding a statistical fate map (Dale and Slack, 1987; Moody, 1987) , would result in an uneven boundary between endoderm and mesoderm or ectoderm, as well as intermingling of tissues. A switch to TGF␤-dependence generates a smooth boundary from the graded signal; it is well known that cells can respond to such a signal by expressing different genes according to the level of signal they receive (Green et al., 1992; Gurdon et al., 1999; Wilson and Melton, 1994) . A critical test of our model will be provided by the analysis of the Xsox17 promoter. This is underway but has proved to be complex, as might have been expected.
Although the earliest events in the induction of endogenous Xsox17 have been elucidated, and a significant role for Xsox17 in endoderm formation has been demonstrated, the molecular basis of the specification of endoderm is still open to investigation. In this study, we have focused on the Xsox17 group, but other transcription factors are also downstream of VegT, including members of the Mix/Mixer/Bix family, and GATAs 4 -6. Of these, we show that the regulation of Mix.1 by VegT has similar properties to that of Xsox17, and Mixer, Milk, and the Bix group have been shown to be direct T-box targets (Casey et al., 1999; Saka et al., 2000; Tada et al., 1998) . It is not yet clear how the activities of these factors are integrated in the early embryo in order to specify endodermal fate, and whether there is functional redundancy between factors with apparently similar endoderm-inducing activity in the animal cap assay.
An important conserved role for the Xsox17 genes is supported by the phenotype of Sox17-null mutant mice, in which there is depletion of gut tissues, particularly posteriorly, and furthermore sox17 Ϫ/Ϫ ES cells were unable to contribute to gut endoderm in chimeras (Kanai-Azuma et al., 2002) . These observations emphasis the pivotal developmental role of Sox17, and support the idea that a least this part of the molecular pathway to endoderm formation is conserved among vertebrates.
